Francesco Salis, Maristella Belfiori, Roberta Agabio, Antonella Mandas
{"title":"老年人酒精-药物相互作用：年龄特异性证据的叙述性回顾","authors":"Francesco Salis, Maristella Belfiori, Roberta Agabio, Antonella Mandas","doi":"10.1093/alcalc/agag018","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Alcohol use is relatively common in older adults, representing a challenge for geriatricians. Older people are also prone to chronically taking multiple medications. Concerns are raised about potential alcohol-medication interactions (AMIs). This review aims to summarize current evidence on AMIs in older adults.</p><p><strong>Methods: </strong>We conducted a literature search using MEDLINE up to 18 June 2025. Of 481 identified studies, 37 were considered pertinent and discussed in this review.</p><p><strong>Results: </strong>Epidemiological data reveal that slightly over 25% (from ~20% to 80%) of older adults concurrently take alcohol and potentially interact with medications. Negative effects related to potential AMIs range from excessive sedation when old people take benzodiazepines, opioids, or antipsychotics, to hypoglycemia when they take sulfonylureas. Pharmacokinetic modifications can depend on physiological age-related changes in the human body. This evidence mostly derives from studies not focused on older adults.</p><p><strong>Conclusions: </strong>Despite their clinical importance, few studies focus on AMIs in older adults. The limited awareness among both healthcare providers and patients represents a significant public health issue. Routine alcohol use screening, universally shared lists of potential AMIs, and larger longitudinal studies are necessary to further explore the theme and mitigate risks.</p>","PeriodicalId":7407,"journal":{"name":"Alcohol and alcoholism","volume":"61 3","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13050505/pdf/","citationCount":"0","resultStr":"{\"title\":\"Alcohol-medication interactions among older people: a narrative review on age-specific evidence.\",\"authors\":\"Francesco Salis, Maristella Belfiori, Roberta Agabio, Antonella Mandas\",\"doi\":\"10.1093/alcalc/agag018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Alcohol use is relatively common in older adults, representing a challenge for geriatricians. Older people are also prone to chronically taking multiple medications. Concerns are raised about potential alcohol-medication interactions (AMIs). This review aims to summarize current evidence on AMIs in older adults.</p><p><strong>Methods: </strong>We conducted a literature search using MEDLINE up to 18 June 2025. Of 481 identified studies, 37 were considered pertinent and discussed in this review.</p><p><strong>Results: </strong>Epidemiological data reveal that slightly over 25% (from ~20% to 80%) of older adults concurrently take alcohol and potentially interact with medications. Negative effects related to potential AMIs range from excessive sedation when old people take benzodiazepines, opioids, or antipsychotics, to hypoglycemia when they take sulfonylureas. Pharmacokinetic modifications can depend on physiological age-related changes in the human body. This evidence mostly derives from studies not focused on older adults.</p><p><strong>Conclusions: </strong>Despite their clinical importance, few studies focus on AMIs in older adults. The limited awareness among both healthcare providers and patients represents a significant public health issue. Routine alcohol use screening, universally shared lists of potential AMIs, and larger longitudinal studies are necessary to further explore the theme and mitigate risks.</p>\",\"PeriodicalId\":7407,\"journal\":{\"name\":\"Alcohol and alcoholism\",\"volume\":\"61 3\",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2026-03-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13050505/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcohol and alcoholism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/alcalc/agag018\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcohol and alcoholism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/alcalc/agag018","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
Alcohol-medication interactions among older people: a narrative review on age-specific evidence.
Aims: Alcohol use is relatively common in older adults, representing a challenge for geriatricians. Older people are also prone to chronically taking multiple medications. Concerns are raised about potential alcohol-medication interactions (AMIs). This review aims to summarize current evidence on AMIs in older adults.
Methods: We conducted a literature search using MEDLINE up to 18 June 2025. Of 481 identified studies, 37 were considered pertinent and discussed in this review.
Results: Epidemiological data reveal that slightly over 25% (from ~20% to 80%) of older adults concurrently take alcohol and potentially interact with medications. Negative effects related to potential AMIs range from excessive sedation when old people take benzodiazepines, opioids, or antipsychotics, to hypoglycemia when they take sulfonylureas. Pharmacokinetic modifications can depend on physiological age-related changes in the human body. This evidence mostly derives from studies not focused on older adults.
Conclusions: Despite their clinical importance, few studies focus on AMIs in older adults. The limited awareness among both healthcare providers and patients represents a significant public health issue. Routine alcohol use screening, universally shared lists of potential AMIs, and larger longitudinal studies are necessary to further explore the theme and mitigate risks.
期刊介绍：
About the Journal
Alcohol and Alcoholism publishes papers on the biomedical, psychological, and sociological aspects of alcoholism and alcohol research, provided that they make a new and significant contribution to knowledge in the field.
Papers include new results obtained experimentally, descriptions of new experimental (including clinical) methods of importance to the field of alcohol research and treatment, or new interpretations of existing results.
Theoretical contributions are considered equally with papers dealing with experimental work provided that such theoretical contributions are not of a largely speculative or philosophical nature.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
